Naomi Nakai, FNP-C
Family · Newark
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Naomi Nakai’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$1,996
Medicare paid this office $1,996 for 19 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 11 | $963 | $88 |
Who their Medicare patients are
19 Original Medicare patients in 2024. Average age 61 · Health risk score 1.01. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 68%.
The office billed $5,121, Medicare allowed $2,817 and paid $1,996; for 43 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 19 | 43 | 61 | 1.01 | $5,121 | $1,996 |
| 2023 | 22 | 34 | 67 | 0.78 | $5,848 | $2,552 |
| 2022 | 27 | 50 | 72 | 1.23 | $17,825 | $5,822 |
| 2017 | 312 | 1,692 | 69 | 1.41 | $58,538 | $39,806 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 1 service
| New patient visit (30+ min) | 11 | $931 | $85 |
2017: 33 services
| Return visit (30+ min) | 226 | $18,473 | $73 |
| Short return visit (20+ min) | 71 | $3,625 | $49 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 134 | $1,515 | $10 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,138 | $103 |
| Confirmation test for antibody to borrelia burgdorferi (lyme disease bacteria) | 20 | $833 | $21 |
| Analysis for antibody borrelia burgdorferi (lyme disease bacteria) | 21 | $801 | $23 |
| Injection of drug or substance into vein | 18 | $790 | $42 |
| New patient visit (30+ min) | 17 | $763 | $45 |
| Detection test by immunoassay with direct visual observation for influenza virus | 30 | $705 | $12 |
| Blood test, comprehensive group of blood chemicals | 63 | $697 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 52 | $626 | $11 |
| Infusion into a vein for hydration, 31-60 minutes | 15 | $585 | $39 |
| Insertion of needle into vein for collection of blood sample | 148 | $467 | $3 |
| Blood test, thyroid stimulating hormone (tsh) | 20 | $452 | $23 |
| Testing for presence of drug, read by direct observation | 24 | $410 | $15 |
| Injection of drug or substance under skin or into muscle | 23 | $403 | $18 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 34 | $400 | $12 |
| Blood test, basic group of blood chemicals (calcium, total) | 35 | $279 | $8 |
| Myoglobin (muscle protein) level | 16 | $272 | $16 |
| Hemoglobin a1c level | 20 | $261 | $13 |
| Inhalation treatment for airway obstruction or sputum production | 15 | $215 | $13 |
| Blood test, lipids (cholesterol and triglycerides) | 16 | $205 | $13 |
| Urinalysis, manual test | 45 | $158 | $3 |
| Creatine kinase (cardiac enzyme) level, mb fraction only | 16 | $141 | $8 |
| Troponin (protein) analysis, quantitative | 16 | $141 | $8 |
| Thyroxine (thyroid chemical), total | 15 | $138 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 44 | $134 | $3 |
| Thyroid hormone evaluation | 15 | $130 | $9 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 21 | $100 | $5 |
| Creatine kinase (cardiac enzyme) level, total | 17 | $82 | $5 |
| Injection, ketorolac tromethamine, per 15 mg | 17 | $26 | None |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 13 | $10 | None |
| Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 14 | $2 | None |
Medicaid work
$1,630 in 2021
Medicaid paid $1,630 for 80 billed services this clinician did in 2021, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 80 | $1,630 |
| 2021 | 80 | 1 | 22 | $1,630 |
Drugs they prescribed that Part D paid
$1,946
Pharmacies billed $1,946 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 58) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
55 generic and fewer than 11 brand-name prescriptions · $1,946 in drug cost · 21 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 58 | 23 | 0% (0) | None | $1,946 |
| 2023 | 244 | 122 | 0% (0) | None | $23,621 |
| 2022 | 2,841 | 464 | None | None | $343,042 |
| 2021 | 774 | 260 | 0% (0) | None | $75,894 |
| 2020 | 229 | 49 | 0% (0) | 15% | $17,605 |
| 2019 | 396 | 81 | 4% (17) | 20% | $39,869 |
| 2018 | 113 | 47 | 0% (0) | 26% | $10,095 |
| 2017 | 502 | 260 | 12% (58) | None | $20,183 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Clopidogrel | 11 | $397 | $36 |
| Carvedilol | 19 | $186 | $10 |
| Atorvastatin | 11 | $157 | $14 |
| Amlodipine Besylate | 15 | $56 | $4 |
| Prednisone | 16 | $23 | $1 |
2022: 46 drugs
| Eliquis | 75 | $71,500 | $953 |
| Brilinta | 23 | $20,385 | $886 |
| Farxiga | 26 | $18,794 | $723 |
| Januvia | 18 | $14,290 | $794 |
| Symbicort | 36 | $14,186 | $394 |
| Trelegy Ellipta | 19 | $12,931 | $681 |
| Vascepa | 18 | $12,350 | $686 |
| Entresto | 11 | $9,858 | $896 |
| Advair Diskus | 20 | $9,720 | $486 |
| Spiriva Respimat | 12 | $6,407 | $534 |
| Clonidine | 18 | $6,202 | $345 |
| Wixela Inhub | 17 | $6,011 | $354 |
| Albuterol Sulfate Hfa | 92 | $3,800 | $41 |
| Atorvastatin | 218 | $2,525 | $12 |
| Carvedilol | 187 | $2,053 | $11 |
| Hydralazine | 102 | $1,936 | $19 |
| Nitroglycerin | 31 | $1,808 | $58 |
| Metoprolol | 81 | $1,656 | $20 |
| Losartan | 202 | $1,545 | $8 |
| Clopidogrel | 67 | $1,314 | $20 |
| Omega-3 Acid Ethyl Esters | 15 | $1,233 | $82 |
| Olmesartan Medoxomil | 25 | $1,178 | $47 |
| Montelukast | 45 | $974 | $22 |
| Rosuvastatin | 24 | $934 | $39 |
| Metolazone | 48 | $904 | $19 |
| Amlodipine Besylate | 122 | $721 | $6 |
| Olmesartan-Hydrochlorothiazide | 13 | $682 | $52 |
| Losartan-Hydrochlorothiazide | 38 | $644 | $17 |
| Metoprolol | 86 | $610 | $7 |
| Digoxin | 20 | $601 | $30 |
| Pantoprazole | 29 | $601 | $21 |
| Fluticasone Propionate | 28 | $593 | $21 |
| Warfarin | 127 | $566 | $4 |
| Levothyroxine | 34 | $550 | $16 |
| Furosemide | 134 | $455 | $3 |
| Minoxidil | 17 | $451 | $27 |
| Omeprazole | 32 | $414 | $13 |
| Simvastatin | 68 | $401 | $6 |
| Hydrochlorothiazide | 30 | $251 | $8 |
| Clonidine | 22 | $196 | $9 |
| Metformin | 41 | $193 | $5 |
| Spironolactone | 17 | $190 | $11 |
| Lisinopril | 33 | $166 | $5 |
| Potassium Chloride | 14 | $136 | $10 |
| Famotidine | 11 | $133 | $12 |
| Azithromycin | 13 | $92 | $7 |
2021: 19 drugs
| Eliquis | 12 | $12,440 | $1,037 |
| Albuterol Sulfate Hfa | 43 | $2,032 | $47 |
| Metoprolol | 25 | $581 | $23 |
| Carvedilol | 49 | $511 | $10 |
| Atorvastatin | 42 | $422 | $10 |
| Hydralazine | 19 | $415 | $22 |
| Losartan | 45 | $405 | $9 |
| Omeprazole | 17 | $275 | $16 |
| Amlodipine Besylate | 38 | $243 | $6 |
| Warfarin | 53 | $199 | $4 |
| Fluticasone Propionate | 12 | $176 | $15 |
| Levothyroxine | 11 | $161 | $15 |
| Clopidogrel | 15 | $157 | $10 |
| Potassium Chloride | 11 | $143 | $13 |
| Simvastatin | 19 | $118 | $6 |
| Furosemide | 30 | $115 | $4 |
| Metoprolol | 11 | $67 | $6 |
| Hydrochlorothiazide | 12 | $51 | $4 |
| Prednisone | 14 | $48 | $3 |
2020: 5 drugs
| Eliquis | 17 | $10,049 | $591 |
| Rosuvastatin | 34 | $1,925 | $57 |
| Metoprolol | 31 | $751 | $24 |
| Atorvastatin | 38 | $601 | $16 |
| Amlodipine Besylate | 24 | $165 | $7 |
2019: 9 drugs
| Eliquis | 37 | $20,513 | $554 |
| Rosuvastatin | 30 | $1,114 | $37 |
| Oxycodone-Acetaminophen | 12 | $808 | $67 |
| Metoprolol | 31 | $799 | $26 |
| Atorvastatin | 33 | $455 | $14 |
| Carvedilol | 14 | $269 | $19 |
| Amlodipine Besylate | 18 | $122 | $7 |
| Metformin | 13 | $108 | $8 |
| Chlorthalidone | 12 | $50 | $4 |
2018: 2 drugs
| Atorvastatin | 14 | $333 | $24 |
| Amlodipine Besylate | 14 | $108 | $8 |
2017: 8 drugs
| Oxycodone-Acetaminophen | 33 | $1,411 | $43 |
| Doxycycline Hyclate | 24 | $474 | $20 |
| Nitrofurantoin Mono-Macro | 13 | $450 | $35 |
| Amoxicillin-Clavulanate Potass | 32 | $434 | $14 |
| Azithromycin | 31 | $159 | $5 |
| Montelukast | 15 | $147 | $10 |
| Alprazolam | 16 | $77 | $5 |
| Amoxicillin | 19 | $57 | $3 |
Money from drug and device companies
$236 in 2022
| 2022 | 7 | 9 | None | $236 |
| 2021 | 3 | 3 | None | $158 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $151 | 3 payments
|
| Philips Electronics North America | (8874) Incourage | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $14 | 1 payment
|
| Amgen | Repatha | $14 | 1 payment
|
| Mylan Specialty L.P. | Yupelri | $13 | 1 payment
|
See all 9 published payments
| Novo Nordisk | Meals · 2022-06-16 | Ozempic | $123 |
| Novo Nordisk | Meals · 2022-06-09 | Rybelsus | $14 |
| Novo Nordisk | Meals · 2022-05-05 | Rybelsus | $14 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2022-04-22 | Ofev | $14 |
| Amgen | Meals · 2022-02-24 | Repatha | $14 |
| Philips Electronics North America | Meals · 2022-02-09 | (8874) Incourage | $17 |
| Novartis Pharmaceuticals | Meals · 2022-02-03 | Entresto | $13 |
| AstraZeneca Pharmaceuticals LP | Meals · 2022-01-14 | Breztri | $14 |
| Mylan Specialty L.P. | Meals · 2022-01-14 | Yupelri | $13 |
See earlier years (2021)
2021: $158
| AstraZeneca Pharmaceuticals LP | Breztri | $125 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $15 | 1 payment
|
Professional record
- NPI
- 1124564018
- Licence
- NY F341307
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 1 Gateway Ctr Ste 2600, Newark, NJ, 07102
- NPI first listed
- 2017-01-16
- NPI last updated
- 2025-11-12
- NPI record certified
- 2025-11-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1101 Wilson Blvd Fl 6, Arlington, VA, 22209 · 950 W Bannock St Ste 1100, Boise, ID, 83702 · 4254 W Orchid Ln, Chandler, AZ, 85226 · 325 N Saint Paul St Ste 3100, Dallas, TX, 75201 · 400 S 4th St Ste 500, Las Vegas, NV, 89101 · 165 Broadway Fl 23, New York, NY, 10006 · 111 N Orange Ave Ste 800, Orlando, FL, 32801 · 195 Page Mill Rd Ste 103, Palo Alto, CA, 94306 · 450 Alaskan Way S Ste 200, Seattle, WA, 98104 · 601 Pennsylvania Ave Nw Bldg Suite900, Washington, DC, 20004